Jordan Rubinson

Jordan Rubinson has more than 20 years of experience in the pharmaceutical industry with large pharma companies like Pfizer, GlaxoSmithKline, and Aventis. He recently worked in early stage companies as a CEO of Regenera Pharma, as a Chief Commercial Officer for Champions Oncology, and was also the CEO of Polyheal Ltd, which was sold to TEVA at a $90M valuation. He worked at Pfizer as the marketing director for Israel, at GSK in U.S. marketing, and at GSK France, managing a large field force division of over 100 employees. While at Aventis, Jordan had assignments in France, Canada and the U.S. He holds an engineering degree from Columbia University and an MBA from MIT.